Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085994450> ?p ?o ?g. }
- W3085994450 endingPage "3263" @default.
- W3085994450 startingPage "3250" @default.
- W3085994450 abstract "Background and Purpose: Although endovascular treatment (EVT) for acute ischemic stroke is classified as I evidence, outcomes after EVT in real-world practice appear to be less superior than those in randomized clinical trials (RCTs). Additionally, the effect of EVT is unclear compared with medical treatment (MT) for patients with mild symptoms defined by National Institutes of Health Stroke Scale score <6 or with severe symptoms defined by Alberta Stroke Program Early CT Score <6. Methods: Literatures were searched in big databases and major meetings from December 6, 2009, to December 6, 2019, including RCTs and observational studies comparing EVT against MT for patients with acute ischemic stroke. Observational studies were precategorized into 3 groups based on imaging data on admission: mild stroke group with National Institutes of Health Stroke Scale score <6, severe stroke group with Alberta Stroke Program Early CT Score <6 or ischemic core ≥50 mL, and normal stroke group for all others. Outcome was measured as modified Rankin Scale score of 0 to 2, mortality at 90 days, and symptomatic intracranial hemorrhage (sICH) at 24 hours. Results: Fifteen RCTs (n=3694) and 37 observational studies (n=9090) were included. EVT was associated with higher modified Rankin Scale 0 to 2 rate and lower mortality in RCTs and normal stroke group, whereas EVT was associated with higher sICH rate in normal stroke group, and no difference of sICH rate appeared between EVT and MT in RCTs. In severe stroke group, EVT was associated with higher modified Rankin Scale 0 to 2 rate and lower mortality, whereas no difference of sICH rate was found. In mild stroke group, there was no difference in modified Rankin Scale 0 to 2 rate between EVT and MT, whereas EVT was associated with higher mortality and sICH rate. Conclusions: Evidence from RCTs and observational studies supports the use of EVT as the first-line choice for eligible patients corresponding to the latest guideline. For patients with Alberta Stroke Program Early CT Score <6, EVT showed superiority over MT, also in line with the guidelines. On the contrary to the guideline, our data do not support EVT for patients with National Institutes of Health Stroke Scale score <6." @default.
- W3085994450 created "2020-09-21" @default.
- W3085994450 creator A5003642180 @default.
- W3085994450 creator A5012278873 @default.
- W3085994450 creator A5029050606 @default.
- W3085994450 creator A5033704754 @default.
- W3085994450 creator A5037373216 @default.
- W3085994450 creator A5037603816 @default.
- W3085994450 creator A5049224082 @default.
- W3085994450 creator A5052282667 @default.
- W3085994450 date "2020-11-01" @default.
- W3085994450 modified "2023-10-17" @default.
- W3085994450 title "Is Endovascular Treatment Still Good for Ischemic Stroke in Real World?" @default.
- W3085994450 cites W1941697624 @default.
- W3085994450 cites W1964435302 @default.
- W3085994450 cites W1969781178 @default.
- W3085994450 cites W1979423827 @default.
- W3085994450 cites W19849081 @default.
- W3085994450 cites W2004751068 @default.
- W3085994450 cites W2009826657 @default.
- W3085994450 cites W2014796100 @default.
- W3085994450 cites W2017206163 @default.
- W3085994450 cites W2020074777 @default.
- W3085994450 cites W2033585778 @default.
- W3085994450 cites W2037399775 @default.
- W3085994450 cites W2059395281 @default.
- W3085994450 cites W2068972986 @default.
- W3085994450 cites W2080504768 @default.
- W3085994450 cites W2083008439 @default.
- W3085994450 cites W2083772654 @default.
- W3085994450 cites W2098032054 @default.
- W3085994450 cites W2098923148 @default.
- W3085994450 cites W2107328434 @default.
- W3085994450 cites W2111559905 @default.
- W3085994450 cites W2112371358 @default.
- W3085994450 cites W2114603310 @default.
- W3085994450 cites W2116475791 @default.
- W3085994450 cites W2118214362 @default.
- W3085994450 cites W2118762534 @default.
- W3085994450 cites W2119542322 @default.
- W3085994450 cites W2119959783 @default.
- W3085994450 cites W2120166248 @default.
- W3085994450 cites W2143237216 @default.
- W3085994450 cites W2148656951 @default.
- W3085994450 cites W2148738704 @default.
- W3085994450 cites W2151475645 @default.
- W3085994450 cites W2153664287 @default.
- W3085994450 cites W2155596541 @default.
- W3085994450 cites W2161374186 @default.
- W3085994450 cites W2171058244 @default.
- W3085994450 cites W2176191911 @default.
- W3085994450 cites W2277258071 @default.
- W3085994450 cites W2302364290 @default.
- W3085994450 cites W2315879714 @default.
- W3085994450 cites W2340489466 @default.
- W3085994450 cites W2340656341 @default.
- W3085994450 cites W2347089146 @default.
- W3085994450 cites W2444482401 @default.
- W3085994450 cites W2462466150 @default.
- W3085994450 cites W2475487380 @default.
- W3085994450 cites W2511388967 @default.
- W3085994450 cites W2511847235 @default.
- W3085994450 cites W2519283910 @default.
- W3085994450 cites W2535348557 @default.
- W3085994450 cites W2551112461 @default.
- W3085994450 cites W2577506013 @default.
- W3085994450 cites W2589884934 @default.
- W3085994450 cites W2604363348 @default.
- W3085994450 cites W2606371730 @default.
- W3085994450 cites W2607057474 @default.
- W3085994450 cites W2614957536 @default.
- W3085994450 cites W2740358637 @default.
- W3085994450 cites W2765373130 @default.
- W3085994450 cites W2765850639 @default.
- W3085994450 cites W2767142829 @default.
- W3085994450 cites W2767776410 @default.
- W3085994450 cites W2787867590 @default.
- W3085994450 cites W2793491181 @default.
- W3085994450 cites W2799595357 @default.
- W3085994450 cites W2800639354 @default.
- W3085994450 cites W2867908783 @default.
- W3085994450 cites W2891574627 @default.
- W3085994450 cites W2892184016 @default.
- W3085994450 cites W2900248444 @default.
- W3085994450 cites W2905190851 @default.
- W3085994450 cites W2909088796 @default.
- W3085994450 cites W2921138980 @default.
- W3085994450 cites W2926772410 @default.
- W3085994450 cites W2938007651 @default.
- W3085994450 cites W2955541202 @default.
- W3085994450 cites W2966489919 @default.
- W3085994450 cites W2971112876 @default.
- W3085994450 cites W2974862198 @default.
- W3085994450 cites W2979004435 @default.
- W3085994450 cites W2980223705 @default.
- W3085994450 cites W2982303713 @default.
- W3085994450 cites W2991090070 @default.
- W3085994450 cites W2994866496 @default.